GEMENETZI, K., F. PSOMOPOULOS, A. A. CARRILES, M. GOUNARI, C. MINICI, Karla PLEVOVÁ, LA SUTTON, M. TSAGIOPOULOU, P. BALIAKAS, K. PASENTSIS, A. ANAGNOSTOPOULOS, R. SANDALTZOPOULOS, R. ROSENQUIST, F. DAVI, Šárka POSPÍŠILOVÁ, P. GHIA, K. STAMATOPOULOS, M. DEGANO and A. CHATZIDIMITRIOU. Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169. Blood. Washington DC, USA: American Society of Hematology, 2021, vol. 137, No 14, p. 1895-1904. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2020005216.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169
Authors GEMENETZI, K., F. PSOMOPOULOS, A. A. CARRILES, M. GOUNARI, C. MINICI, Karla PLEVOVÁ (203 Czech Republic, belonging to the institution), LA SUTTON, M. TSAGIOPOULOU, P. BALIAKAS, K. PASENTSIS, A. ANAGNOSTOPOULOS, R. SANDALTZOPOULOS, R. ROSENQUIST, F. DAVI, Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution), P. GHIA, K. STAMATOPOULOS, M. DEGANO and A. CHATZIDIMITRIOU (guarantor).
Edition Blood, Washington DC, USA, American Society of Hematology, 2021, 0006-4971.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30205 Hematology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 25.476
RIV identification code RIV/00216224:14740/21:00124275
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1182/blood.2020005216
UT WoS 000646123500011
Keywords in English CLL; subsets 2 and 169; immunoglobulin
Tags 14110212, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 28/2/2022 16:45.
Abstract
Chronic lymphocytic leukemia (CLL) major stereotyped subset 2 (IGHV3-21/IGLV3-21, similar to 2.5% of all cases of CLL) is an aggressive disease variant, irrespective of the somatic hypermutation (SHM) status of the clonotypic IGHV gene. Minor stereotyped subset 169 (IGHV3-48/IGLV3-21, similar to 0.2% of all cases of CLL) is related to subset 2, as it displays a highly similar variable antigen-binding site. We further explored this relationship through next-generation sequencing and crystallographic analysis of the clonotypic B-cell receptor immunoglobulin. Branching evolution of the predominant clonotype through intraclonal diversification in the context of ongoing SHM was evident in both heavy and light chain genes of both subsets. Molecular similarities between the 2 subsets were highlighted by the finding of shared SHMs within both the heavy and light chain genes in all analyzed cases at either the clonal or subclonal level. Particularly noteworthy in this respect was a ubiquitous SHM at the linker region between the variable and the constant domain of the IGLV3-21 light chains, previously reported as critical for immunoglobulin homotypic interactions underlying cell-autonomous signaling capacity. Notably, crystallographic analysis revealed that the IGLV3-21-bearing CLL subset 169 immunoglobulin retains the same geometry and contact residues for the homotypic intermolecular interaction observed in subset 2, including the SHM at the linker region, and, from a molecular standpoint, belong to a common structural mode of autologous recognition. Collectively, our findings document that stereotyped subsets 2 and 169 are very closely related, displaying shared immunoglobulin features that can be explained only in the context of shared functional selection.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 10/5/2024 01:48